Conditions: Hypercholesterolemia Dyslipidemia Coronary Heart Disease
Keywords: hypercholesterolemia dyslipidemia CHD pitavastatin simvastatin 2 or more risk factors for coronary heart disease combined dyslipidemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 178
Healthy volunteers: no

Brief summary:
This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

Detailed description:
This is a sixteen-week, double-blind, active controlled, follow-on and 28 week single blind extension study for patients who participated in NK-104-304.

Arms:
arm 1: Pitavastatin 4 mg once daily arm 2: Simvastatin 40 mg or 80 mg once daily

Interventions: intervention 1: pitavastatin intervention 2: simvastatin
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: